Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
NexGel Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
1,30 -0,76 -0,01 15 045
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiNexgel Inc
TickerNXGL
Kmenové akcie:Ordinary Shares
Kmenové akcie:Ordinary Shares
RICNXGL.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 19
Akcie v oběhu k 12.11.2025 8 143 133
MěnaUSD
Kontaktní informace
Ulice2150 Cabot Blvd West,, Suite B
MěstoLANGHORNE
PSČ19047
ZeměUnited States
Kontatní osobaValter Pinto
Funkce kontaktní osobyInvestor Relations
Telefon12 157 028 550
Fax13026365454
Kontatní telefon12 128 961 254

Business Summary: NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Nexgel Inc revenues increased 53% to $8.6M. Net loss decreased 16% to $2M. Revenues reflect Nexgel segment increase of 50% to $6.6M, CGN JV segment increase of 62% to $2.1M. Lower net loss reflects CGN JV segment income totaling $177K vs. loss of $404K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to -$0.26.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSPlastics Bag and Pouch Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Biological Product (exc Diagnostic) Mfg
NAICS2007Medical Laboratories
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Biological Product (except Diagnostic) Manufacturing
NAICS1997Medical Laboratories
SICPharmaceutical Preparations
SICBags: Plastics/laminated/coated
SICCommercial Physical Research



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorAdam Levy6209.09.202110.09.2019
Interim Chief Financial Officer, Principal Financial Officer, Principal Accounting OfficerAdam Drapczuk5001.01.202501.06.2021